Screener
Charles River Laboratories CRL Payments for Repurchase of Common Stock
Payments for Repurchase of Common Stock at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.
The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 9:21 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001100682-26-000118
| Line item | Six Months Ended / June 27, 2026 | Six Months Ended / June 28, 2025 |
|---|---|---|
| Proceeds from long-term debt and revolving credit facility | 1,265,258 | 963,363 |
| Payments on long-term debt, revolving credit facility, and finance lease obligations | (745,927) | (887,706) |
| Proceeds from exercises of stock options | 1,620 | 1 |
| Purchase of treasury stock | (323,881) | (360,484) |
| Payments of contingent consideration | (11,400) | (21,822) |
| Purchase of remaining equity interests of other redeemable noncontrolling interest | — | (19,140) |
| Other, net | (2,607) | (6,458) |
| Net cash provided by (used in) financing activities | 183,063 | (332,246) |
Item 1. Financial Statements
FAQ
- What is Charles River Laboratories's payments for repurchase of common stock?
- Charles River Laboratories (CRL) reported payments for repurchase of common stock of $115.6M in Q2 2026.
- How has Charles River Laboratories's payments for repurchase of common stock changed year-over-year?
- Charles River Laboratories's payments for repurchase of common stock increased by 1472.3% year-over-year, from $7.35M to $115.6M.
- What is the long-term trend for Charles River Laboratories's payments for repurchase of common stock?
- Over 4 years (2021 to 2025), Charles River Laboratories's payments for repurchase of common stock has grown at a 72.5% compound annual growth rate (CAGR), from $40.71M to $360.67M.
- What does payments for repurchase of common stock mean?
- Represents the total cash outflow used by the company to buy back its own shares from the open market or through private transactions. This activity is a key component of capital allocation strategy, often used to return excess capital to shareholders or offset dilution from employee equity programs.
Ask your AI about Charles River Laboratories's payments for repurchase of common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude